Biohaven Ltd.
BHVN
$21.88
$0.140.64%
NYSE
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/29/2025
-
MarketBeat
4/29/2025
-
MarketBeat
4/28/2025
-
Fool.com Headlines
4/28/2025
-
GuruFocus
4/28/2025
-
PR Newswire
4/27/2025
-
MarketBeat
4/25/2025
-
Fool.com Headlines
4/25/2025
-
MarketBeat
4/24/2025
-
MarketBeat
4/23/2025
-
Insider Monkey
4/23/2025
-
Insider Monkey
4/23/2025
-
MarketBeat
4/22/2025
-
GuruFocus
4/22/2025
-
PR Newswire
4/22/2025
-
Insider Monkey
4/21/2025
-
Globe Newswire
4/20/2025
-
MarketBeat
4/18/2025
-
MarketBeat
4/18/2025
-
MarketBeat
4/17/2025
-
Stock Options Channel
4/17/2025
-
Globe Newswire
4/16/2025
-
MarketBeat
4/15/2025
-
GuruFocus
4/15/2025
-
PR Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 3, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
203 404 0410
Address
215 Church Street
New Haven, CT 06510
New Haven, CT 06510
Country
Year Founded
Business Description
Sector
Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide. The company develops troriluzole, which is in Phase 3 trial for the treatment...
more